A Randomized, Placebo-Controlled, Double-Blind, Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel (Nab-Paclitaxel, Abraxane®) With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 28 Sep 2017
At a glance
- Drugs Paclitaxel (Primary) ; Mifepristone
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 12 Apr 2017 Status changed from not yet recruiting to recruiting.
- 28 Nov 2016 Planned initiation date changed from 1 Aug 2016 to 1 Dec 2016.